Sramana Mitra: We have a lot of activity right now in Europe. Recently in the last Fall, we announced a partnership with EIT Health. These are all healthcare IT companies. That’s probably aligned with your investment thesis. How about a few examples of deals that you have invested in and a little bit of a commentary on what is it in those deals that spoke to you? At what stage did you encounter them? How did you encounter them and why did they speak to you?
Frank Malek: Let me start with the trends that we’re seeing because we are looking for trends where we see opportunity. As I mentioned earlier, we love healthcare. We have had several exits around healthcare. The trend that we’re seeing right now is around AI and machine learning (ML). For example, we like where AI and ML technologies can be applied to healthcare and also to improve customer engagement or workflow automation around clinical trials. >>>
Sramana Mitra: Let’s double click down on your portfolio. In what shape did they come to you? What stage? What is it about them that attracted you enough for you to make the investment?
Daniel Keiper-Knorr: Typically, we try to be the first institutional investor coming on the cap table. However, we don’t see ourselves as a typical institutional investor because we run a very specific model that differs significantly from the standard two and twenty VC model. Apart from managing €50 million as supported by two to three principals and double the number of analysts and associates, our model is different. >>>
Sramana Mitra: Let’s say we send you a company. You will figure out from your network who is the likely investor that you want to do the deal with and have them price the deal and lead the deal. Is that what you’re saying?
Frank Malek: Yes, we prefer that. That’s right.
Sramana Mitra: You said you invest all over Europe and North America. >>>
Responding to a popular request, we are now sharing transcripts of our investor podcast interviews in this new series. The following interview with Daniel Keiper-Knorr was recorded in January 2019.
Daniel Keiper-Knorr is Founder and General Partner at Speedinvest, a venture firm based in Vienna. It’s great to see exciting energy and activity in Vienna, one of my favorite cities.
Sramana Mitra: Let’s start by getting you acquainted with our community. Tell us about you. >>>
Responding to a popular request, we are now sharing transcripts of our investor podcast interviews in this new series. The following interview with Frank Malek was recorded in January 2019.
Frank Malek is General Partner at Impacteo, an impact investment fund that invests in companies in the US and in Europe. This includes companies in digital health, climate change, FinTech, etc.
Sramana Mitra: Let’s start by introducing our audience to you and to Impacteo. Tell us about your background. What is the investment thesis of Impacteo? >>>
In case you missed it, you can listen to the recording here:
During this week’s roundtable, we had as our guest Rebecca Kaden, General Partner at Union Square Ventures. We discussed her firm’s capital efficient investment thesis and debated the pros and cons of blitzscaling.
Wellnesys
As for entrepreneur pitches, up first Muralidhar Somisetty from Bangalore, India, pitched Wellnesys, a digital powered yoga mat to help corporations offer personalized wellness services to their employees. We discussed business model and pricing model as it pertains to validation.
Matt Holleran, General Partner at Cloud Apps Capital Partners, talks about his firm’s investment thesis in what he calls classic Series A. His is one of the rare firms that invest at the concept stage.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | Google Play | Stitcher | TuneIn | RSS